JNJ

2024Q4BMO

Johnson & Johnson primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2025-01-22 · Fiscal end 2024-12-31 · Features as of 2025-01-21

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS2.01
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move1.0%
IV front—
P/C full—
P/C front—
Features as of2025-01-21

Run-up

Close—
Ret 5d+2.5%
Ret 10d+2.7%
Ret 20d+2.3%
Ret 30d-1.5%

Post-Earnings Data

Results & reaction

Print

Actual EPS
2.04Beat
Estimated EPS2.01
Actual revenue
22.5B
Surprise %+1.5%
Beat / missBeat
Beat streak 44
Beat streak 88

Reaction

1-day stock reaction+0.9%
Implied vs actual

Implied 1.0%Actual 2.8%

Gap reaction-2.8%
Day result-1.9%
Next-day upYes
Realized / IV2.74×

Post tape

Post 5d+4.0%
Post 10d+6.5%
Post volume16.8M
Vol ×10d1.80×
Vol ×20d2.02×
Post range2.3%